Canada markets closed

NeutriSci International Inc. (NRXCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1058-0.0019 (-1.76%)
At close: 3:14PM EDT

NeutriSci International Inc.

609 Granville Street
Suite 1600
Vancouver, BC V7Y 1C3
Canada

http://www.neutrisci.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Glen RehmanCEO, Pres & Director128.31kN/AN/A
Mr. John Robert ChisholmChief Financial OfficerN/AN/A1962
Mr. Thierry SorhaitzVP of Sales & MarketingN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada. Its products include Neuenergy, an energy tablet designed to deliver enhanced focus and mental clarity; and BluScience, a nutraceutical product. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with Cryopharm Corporation, LaSanta Botanicals, Nutritional High, and Naturally Splendid. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Corporate Governance

NeutriSci International Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.